Document is current
Any future updates will be listed below
-
Authors
Friedel, Anna Lena
Schock, Lisa https://orcid.org/0009-0009-0615-5752
Siegel, Sonja
Fritz, Angelika Hiroko
Unger, Nicole
Harbeck, Birgit
Dammann, Philipp
Kreitschmann-Andermahr, Ilonka
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Accepted: 15 September 2024
First Online: 25 September 2024
Declarations
:
: Since this study did not contain any real patient data, an ethics vote was not obtained.
: IKA and NU and JH received research support and/or travel grants and/or lecture or advisory board honoraria from Recordati Rare Diseases GbmH Germany, IPSEN Pharma GmbH Germany, Advanz Pharma GmbH, Pfizer Pharma GmbH Germany and Pfizer Co., all of which are manufactures of acromegaly medications. SoS received research support and/or travel grants and/or consultation fees from IPSEN Pharma GmbH Germany, Advanz Pharma GmbH, Pfizer Pharma GmbH Germany and Pfizer Inc. BH received research support and/or travel grants and/or lecture or advisory board honoraria from Recordati Rare Diseases GmbH, Pfizer Pharma GmbH Germany and Alexion Pharma Germany GmbH. LS, ALF, AHF and PD declare to have no conflict of interest in relation to the content of this article.
